Answers are grounded in this paper and cite their sources.
Case report demonstrates sustained complete remission of AA amyloidosis in cystic fibrosis, indicating CFTR modulators can resolve systemic inflammatory complications.
CFTR modulators have been revolutionary for cystic fibrosis patients but their potential influence on AA amyloidosis has not been investigated. This case report is of a gentleman with cystic fibrosis and nephrotic range proteinuria secondary to AA amyloidosis. At five years following commencement of CFTR modulators, he is in sustained, complete remission with normal urine protein excretion and serum amyloid protein levels within the normal range.
No takes yet. Share an insight, caveat, or question.
McDougall et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: